RxDoctor Payments Data

Maria Fiel, MD

Anatomic Pathology & Clinical Pathology · New York, NYNPI 1518967421

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,787 of the $42,177 with a category attached, or 89.6%. 5 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 36.3% of the total. Reporting peaked in 2023 at $15,914 and has fallen 51.5% since, to $7,722 in 2024. Among anatomic pathology & clinical pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,177in general payments, 2019–2025

Across 29 payments — averaging $1454.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$15K
  • Merck$15K
  • AstraZeneca$7K
  • Regeneron$5K
  • Aadi Bioscience, Inc.$36
$1,569in research payments, 2019–2025

Across 8 payments — averaging $196.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K

What the payments were for

  • Consulting fees$37,78790%
  • Speaking & faculty fees$3,2008%
  • Travel & lodging$7112%
  • Food & beverage$4791%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.6$15,314
Merck9$14,665
AstraZeneca7$6,876
Regeneron6$5,286
Aadi Bioscience, Inc.1$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,177 in reported general payments places this provider in the 95th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York

Medicare billing

Part B allowed, 2024
$112,463
Medicare patients
471
Services billed
1,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →